High-Risk Neuroblastoma
Nano targeted induction of dual ferroptotic mechanisms eradicates high risk neuroblastoma
16
Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
8
Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
11
Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients
11
Models of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcome
12
Combined Treatment Strategy and Outcome of High Risk Neuroblastoma: Experience of the Children’s Cancer Hospital Egypt
8
Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma
23
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
12
The Impact of Pretransplant Disease Characteristics on the Outcome of Autologous Stem Cell Transplantation for Neuroblastoma with High Risk Features: A Retrospective Model from a Limited Resources Country
11
Neuroblastoma in Saudi Children: A Single Center Experience (2006 2014)
10
RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes
13
The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
11
Infection of peripheral blood mononuclear cells and cell lines by cell free human T cell lymphoma/leukemia virus type I
6
Insights into Neuroblastoma Initiation and Disease Progression Through integrative Genomics and Epigenomics
142
Polymorphisms in <em>MYCN</em> gene and neuroblastoma risk in Chinese children: a 3-center case–control study
10
Levels of anxiety in high risk pregnant women
6
Expression of Chemokine Receptor CXCR4 in Primary and Metastatic Neuroblastoma Expression of CXCR4 in Neuroblastoma
7
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma
12
NEUROBLASTOMA SYMPATHETICUM
15
NEUROBLASTOMA IN CHILDHOOD
8